ANAPTYSBIO, INC (ANAB) Form 8-K Material Events
ANAPTYSBIO, INC (ANAB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANAB
CIK: 1370053
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChristopher Finley
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001187333-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009921 | View SEC Doc Filr Page |
| 10-KT | 2026-09-21 | 2026-06-30 | 10-KT | 0001193125-26-396696 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-21 | 8-K | 0001193125-26-396690 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001477384-26-000013 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005200 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344583 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-03-12 | 4 Filing | 0001711462-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-03-12 | 4 Filing | 0001673528-26-000016 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-28 | 8-K | 0001193125-26-326097 | View SEC Doc Filr Page |
| 144 | 2026-07-13 | — | 144 Filing | 0001950047-26-007028 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006633 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001950047-26-006580 | View SEC Doc Filr Page |
| ARS | 2026-06-29 | 2025-12-31 | ARS | 0001193125-26-288436 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-29 | — | DEFA14A | 0001193125-26-288431 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-29 | 2026-06-29 | DEF 14A | 0001193125-26-288408 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001950047-26-006565 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-15 | 8-K | 0001193125-26-277505 | View SEC Doc Filr Page |
| 144 | 2026-06-17 | — | 144 Filing | 0001950047-26-006265 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001478916-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001187333-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001477384-26-000010 | View SEC Doc Filr Page |
| 144 | 2026-06-16 | — | 144 Filing | 0001950047-26-006237 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001950047-26-006156 | View SEC Doc Filr Page |
| 144 | 2026-06-12 | — | 144 Filing | 0001950047-26-005990 | View SEC Doc Filr Page |